Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A mir-153 binding site variation in SNCA in a patient with Parkinson's disease.

Literature DB >> 23674501

A mir-153 binding site variation in SNCA in a patient with Parkinson's disease.

Han-Joon Kim¹, Gibeom Park, Beom S Jeon, Woong Yang Park, Young Eun Kim.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23674501 DOI： 10.1002/mds.25505

Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

Review 1. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

Authors: Subhrangshu Guhathakurta; Eugene Bok; Baggio A Evangelista; Yoon-Seong Kim
Journal: Prog Neurobiol Date: 2017-04-23 Impact factor: 11.685

2. MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.

Authors: Peter T Nelson; Wang-Xia Wang; Sarah A Janse; Katherine L Thompson
Journal: Brain Res Date: 2017-11-13 Impact factor: 3.252

3. The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.

Authors: Huanyu Xu; Liron Abuhatzira; Gilberto N Carmona; Suryakiran Vadrevu; Leslie S Satin; Abner L Notkins
Journal: Diabetologia Date: 2015-07-04 Impact factor: 10.122

4. LncRNA FER1L4 promotes differentiation and inhibits proliferation of NSCs via miR-874-3p/Ascl2.

Authors: Yanping Li; Hui Wang; Liping Zhan; Qingyun Li; Yang Li; Gang Wu; Huan Wei; Xiaolin Dong
Journal: Am J Transl Res Date: 2022-04-15 Impact factor: 3.940

5. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

Authors: Lidia Tagliafierro; Omolara-Chinue Glenn; Madison E Zamora; Thomas G Beach; Randy L Woltjer; Michael W Lutz; Ornit Chiba-Falek
Journal: Alzheimers Dement Date: 2017-04-18 Impact factor: 21.566

A mir-153 binding site variation in SNCA in a patient with Parkinson's disease.

Review 1. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

2. MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.

3. The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.

4. LncRNA FER1L4 promotes differentiation and inhibits proliferation of NSCs via miR-874-3p/Ascl2.

5. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

6. Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.

Review 7. Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.

Review 8. MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson's Disease.

Review 9. MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.